Search clinical trials for: bimatoprost 6 µg generation 2

Total 1015 results

Allergan

Completed

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States, Israel, Canada, Singapore, Philippines, Spain, Australia, Belgium, Brazil, Germany
Statens Serum Institut

Completed

Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers

Tuberculosis

Netherlands
Shanxi Medical University
Centers for Disease Control and Prevention, China

Not yet recruiting

Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population

Hepatitis B Vaccine

China
Shanxi Medical University
Centers for Disease Control and Prevention, China

Not yet recruiting

Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients

Hepatitis B Vaccine

China
AbbVie

Completed

A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Chiesi Farmaceutici S.p.A.

Completed

TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA (TRIMARAN)

Asthma

Germany
Shanxi Medical University
Centers for Disease Control and Prevention, China

Not yet recruiting

Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Hepatitis B Vaccine

China
GlaxoSmithKline
CureVac

Completed

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

SARS-CoV-2

United States
Allergan

Completed

A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)

Alopecia | Alopecia, Androgenetic | Baldness

United States
Chiesi Farmaceutici S.p.A.

Completed

Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients

Asthma

Italy
Ocular Therapeutix, Inc.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Open Angle Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss

Alopecia | Baldness

United States, Germany
Allergan

Completed

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Chiesi Farmaceutici S.p.A.

Completed

TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER) (TRIGGER)

Asthma

Argentina, Belarus, Bulgaria, Czechia, Germany, Hungary, Italy, Lithuania, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Turkey, Ukraine, United Kingdom
INSYS Therapeutics Inc

Withdrawn

Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain

Acute Pain

United States
Chiesi Farmaceutici S.p.A.

Completed

Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD

Chronic Obstructive Pulmonary Disease

France
Chiesi Farmaceutici S.p.A.

Completed

Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients (ADO pMDI)

Asthma

Poland
Medstar Health Research Institute
Latham Fund

Recruiting

Treatment of Hypopigmented Scars With Bimatoprost

Burn Scar | Cicatrix | Scars | Cicatrix, Hypertrophic | Pigmentation Disorder | Scarring | Hypopigmented Skin | Hypopigmented Scar | Burns Laser

United States
Baylor Research Institute

Enrolling by invitation

Continuous Glucose Monitoring of Hospitalized Patients With Diabetes

Diabetes Mellitus | Diabetes | Glucose, Low Blood | Glucose, High Blood

United States
Health Institutes of Turkey
TC Erciyes University

Completed

Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19

COVID-19

Turkey
Allergan

Completed

Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Primary Open-Angle Glaucoma

United States
Chiesi Farmaceutici S.p.A.

Completed

A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler

Asthma

United Kingdom
Hvivo
GlaxoSmithKline

Completed

Development of an Intranasal Proteosome Influenza Vaccine

Influenza
Institut Pasteur
Wellcome Trust; Walter Reed Army Institute of Research (WRAIR); Parexel; Bill &... and other collaborators

Completed

A Study to Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a (GlycoShig3)

Healthy

Kenya
Fluart Innovative Vaccine Ltd, Hungary

Completed

Safety of 4Fluart ID Suspension for Injection in Adult Subjects

Human Influenza

Hungary
Ahmed Hassan Nouh MD

Completed

Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata

Alopecia Areata

Egypt
Sanofi

Completed

Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers

Clostridium Infections

United States
Boston University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Not yet recruiting

The Role of Vitamin K on Knee Osteoarthritis Outcomes

Osteo Arthritis Knee

United States
Urovant Sciences GmbH
Dasman Diabetes Institute; Ion Channel Innovations

Completed

Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED

Erectile Dysfunction

Kuwait
Tunitas Therapeutics, Inc.
Tunitas Therapeutics Australia Pty Ltd

Terminated

Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects

Allergy and Immunology

Australia
University of Ulster
University of Bergen; University of Dublin, Trinity College

Completed

Vitamin B12 Biomarker Responses to Supplementation

Healthy

United Kingdom
Kocak Farma

Recruiting

Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo

COVID-19 Vaccine

Turkey
Dr. Soetomo General Hospital
Indonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, Indonesia

Recruiting

UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)

COVID-19 Pandemic | COVID-19 Vaccines

Indonesia
University of Louisville

Completed

Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury

Spinal Cord Injury

United States
Cell Energy Life Sciences Group Co. LTD
Beijing 302 Hospital

Recruiting

Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases

Lung Injury

China
Eurocine Vaccines AB

Completed

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU

Influenza, Human

Sweden
Universidad Complutense de Madrid

Recruiting

Clinical Efficacy of Different Revision Times in the Reulceration Rate in Persons With Diabetes and Remission (Diatime)

Diabetic Foot

Spain
Chiesi Farmaceutici S.p.A.

Completed

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)

COPD (Chronic Obstructive Pulmonary Disease)

China, Korea, Republic of, Taiwan
Chiesi Farmaceutici S.p.A.

Terminated

A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) (FAIR)

Chronic Obstructive Pulmonary Disease

Netherlands
Chiesi Farmaceutici S.p.A.
SGS S.A.

Recruiting

Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

Asthma

Belgium
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Enasidenib as Maintenance Therapy in Treating Patients With Acute Myeloid Leukemia With IDH2 Mutation After Donor Stem Cell Transplant

Acute Myeloid Leukemia

United States
University of Pennsylvania

Active, not recruiting

Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT

Parkinson Disease | Healthy Volunteer

United States
Novan, Inc.
Novella Clinical

Completed

A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis

Atopic Dermatitis

United States
Institute for Clinical and Experimental Medicine

Completed

Effect of Meal Frequency on Insulin Resistance in Subjects With Type 2 Diabetes (Frequency)

Diabetes Mellitus, Type 2

Czech Republic
Chiesi Farmaceutici S.p.A.

Completed

Triple in Asthma Dose Finding (Triskel)

Asthma

Bulgaria, Germany, Hungary, Italy, Poland, United Kingdom
Boehringer Ingelheim

Completed

A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, Netherlands, Denmark, France, South Africa, Austria, Belgium, Sweden
University of Pennsylvania

Recruiting

Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT

Cardiac Amyloidosis

United States
Laboratorios Ordesa
Sprim Advanced Life Sciences

Terminated

Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy (GRITO-14)

Cow's Milk Allergy

Spain, France
Chiesi SAS
Kappa Santé

Recruiting

Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study (TriNEXT)

COPD

France
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States

3

Subscribe